Janssen Pharms., Inc. v. Teva Pharms. USA, Inc. - Invega Sustenna® (Paliperidone Palmitate) - Distinguished
Beautiful girl with dark hair Oriental appearance, dancing among the fields of flowers at sunset. The image on the background of picturesque hills. Fashionable tinted. Creative color.

Janssen Pharms., Inc. v. Teva Pharms. USA, Inc. – Invega Sustenna® (Paliperidone Palmitate)

Start
Case Name: Janssen Pharms., Inc. v. Teva Pharms. USA, Inc., No. 2022-1258, 2022-1307, 2024 WL 1355733 (Fed. Cir. Apr. 1, 2024) (Circuit Judges Dyk, Prost, and Hughes presiding; Opinion by Prost, J.) (Appeal from D.N.J., Cecchi, J.)….
By: Robins Kaplan LLP
Previous Story

How the Timing of Director Review May Affect Co-Pending Litigation

Next Story

RegFi Episode 42: Beyond the Breach: The CISO’s Role as a Strategic Risk Manager